About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Adaptive RadioTherapy for OroPharynx Cancer | Clinical Trials | Clareo Health

RECRUITINGPhase 2

Adaptive RadioTherapy for OroPharynx Cancer

Adaptive RadioTherapy for Locally Advanced OroPharynx Cancer (ART-OPC) A Phase II Randomized Trial

NCT04901234•Centre hospitalier de l'Université de Montréal (CHUM)

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Oropharynx CancerRadiotherapy; ComplicationsRadiotherapy Side Effect+2 more

Interventions

Standard radiotherapy +/- chemotherapy

Experimental radiotherapy +/- chemotherapy

Locations

2

Australia

Locations (2)

Austin Health

Melbourne, Australia

Centre Hospitalier de l'Université de Montréal

Montreal, Quebec, Canada

Key Dates

Start Date

July 30, 2021

Primary Completion Date

December 1, 2024

Completion Date

December 1, 2026

Last Updated

December 12, 2023

Related Studies

RECRUITINGPhase 2

A Study on Using Cell-Free Tumor DNA (ctDNA) Testing to Decide When to StartRoutine Treatment in People With Human Papilloma Virus (HPV)- Associated Oropharynx Cancer (OPC)

NCT05307939

HPVOropharynx Cancer+3 more

RECRUITINGPhase 1/2

E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers

NCT05639972

HPV-Associated Cervical CarcinomaHPV-Related Carcinoma+15 more

Achieving a Better Outcome Through Limiting the Glioblastoma Clinical Target Volume

NCT06719440

GlioblastomaRadiotherapy Side Effect

RECRUITINGPhase 2

Personalized Volume-deescalated Elective Nodal Irradiation in Oropharyngeal Head and Neck Squamous Cell Carcinoma

NCT06563362

Oropharynx Cancer

RECRUITINGPhase 2

Selective Adjuvant Therapy for HPV-mediated Oropharynx SCCs Based on Residual Circulating Tumor DNA Levels (SAVAL)

NCT06088381

Head and Neck CancerHead and Neck Squamous Cell Carcinoma+3 more

RECRUITINGPhase 2

Radiotherapy by Sonic Hedgehog Pathway Inhibitors in Basal Cell Carcinoma

NCT05561634

Basal Cell CarcinomaRadiotherapy; Complications

View all related studies

Sponsors

Lead Sponsor

Centre hospitalier de l'Université de Montréal (CHUM)

Collaborators

Austin Health

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 12, 2023Data synced to Clareo: April 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions